Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Longeveron (LGVN) Research & Development (2020 - 2025)

Longeveron has reported Research & Development over the past 6 years, most recently at $2.7 million for Q4 2025.

  • Quarterly results put Research & Development at $2.7 million for Q4 2025, up 36.75% from a year ago — trailing twelve months through Dec 2025 was $12.0 million (up 48.0% YoY), and the annual figure for FY2025 was $12.0 million, up 47.98%.
  • Research & Development for Q4 2025 was $2.7 million at Longeveron, down from $3.9 million in the prior quarter.
  • Over the last five years, Research & Development for LGVN hit a ceiling of $3.9 million in Q3 2025 and a floor of $1.3 million in Q1 2022.
  • Median Research & Development over the past 5 years was $2.2 million (2023), compared with a mean of $2.3 million.
  • Biggest five-year swings in Research & Development: soared 367.13% in 2021 and later tumbled 37.74% in 2023.
  • Longeveron's Research & Development stood at $1.7 million in 2021, then skyrocketed by 88.29% to $3.3 million in 2022, then plummeted by 33.93% to $2.2 million in 2023, then fell by 7.75% to $2.0 million in 2024, then skyrocketed by 36.75% to $2.7 million in 2025.
  • The last three reported values for Research & Development were $2.7 million (Q4 2025), $3.9 million (Q3 2025), and $3.0 million (Q2 2025) per Business Quant data.